These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 25531014)

  • 41. A clinical trial of a novel emulsion for potential use as a saliva substitute in patients with radiation-induced xerostomia.
    Apperley O; Medlicott N; Rich A; Hanning S; Huckabee ML
    J Oral Rehabil; 2017 Nov; 44(11):889-895. PubMed ID: 28741683
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of carboxymethylcellulose (CMC)-based artificial saliva in patients with xerostomia.
    Oh DJ; Lee JY; Kim YK; Kho HS
    Int J Oral Maxillofac Surg; 2008 Nov; 37(11):1027-31. PubMed ID: 18640823
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Study on Duration of Effect of Transcutaneous Electrical Nerve Stimulation Therapy on Whole Saliva Flow.
    Bhasin N; Reddy S; Nagarajappa AK; Kakkad A
    J Contemp Dent Pract; 2015 Jun; 16(6):479-85. PubMed ID: 26323452
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Managing complications of radiation therapy in head and neck cancer patients: Part I. Management of xerostomia.
    Ngeow WC; Chai WL; Rahman RA; Ramli R
    Singapore Dent J; 2006 Dec; 28(1):1-3. PubMed ID: 17378333
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of salivary hypofunction during and after radiotherapy.
    Shiboski CH; Hodgson TA; Ship JA; Schiødt M
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103 Suppl():S66.e1-19. PubMed ID: 17379158
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Use of hydroxy-propyl-methyl cellulose (methocel) and carboxy-methyl cellulose containing artificial saliva in the symptomatic treatment of xerostomia].
    Nagy G; Olveti E; Zeher M; Márton S; Keszthelyi G
    Fogorv Sz; 1995 Sep; 88(9):299-304. PubMed ID: 8522026
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnosis and management of the dry mouth: Part 1.
    Pankhurst CL; Smith EC; Rogers JO; Dunne SM; Jackson SH; Proctor G
    Dent Update; 1996 Mar; 23(2):56-62. PubMed ID: 8948194
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Theses 25 years after date 23. Developments in the prevention and treatment of xerostomia].
    Vissink A
    Ned Tijdschr Tandheelkd; 2010 Sep; 117(9):453-9. PubMed ID: 20968105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The effect of mucin-containing artificial saliva on severe xerostomia.
    'S-Gravenmade EJ; Roukema PA; Panders AK
    Int J Oral Surg; 1974; 3(6):435-9. PubMed ID: 4217320
    [No Abstract]   [Full Text] [Related]  

  • 50. Xerostomia--clinical evaluation and treatment in general practice.
    Daniels TE; Wu AJ
    J Calif Dent Assoc; 2000 Dec; 28(12):933-41. PubMed ID: 11323948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preparation and clinical evaluation of a high viscosity saliva substitute.
    van der Bijl P; de Waal J
    J Dent Assoc S Afr; 1994 Jun; 49(6):299-303. PubMed ID: 9508950
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bioadhesive, rheological, lubricant and other aspects of an oral gel formulation intended for the treatment of xerostomia.
    Kelly HM; Deasy PB; Busquet M; Torrance AA
    Int J Pharm; 2004 Jul; 278(2):391-406. PubMed ID: 15196643
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Aging-related changes in quantity and quality of saliva: Where do we stand in our understanding?
    Xu F; Laguna L; Sarkar A
    J Texture Stud; 2019 Feb; 50(1):27-35. PubMed ID: 30091142
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pilocarpine and artificial saliva for the treatment of xerostomia and xerophthalmia in Sjögren syndrome: a double-blind randomized controlled trial.
    Cifuentes M; Del Barrio-Díaz P; Vera-Kellet C
    Br J Dermatol; 2018 Nov; 179(5):1056-1061. PubMed ID: 29432648
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of the application of a mucin-based saliva substitute on the oral microflora of xerostomic patients.
    Weerkamp AH; Wagner K; Vissink A; Gravenmade EJ
    J Oral Pathol; 1987 Oct; 16(9):474-8. PubMed ID: 3123626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug induced xerostomia. The effects and treatment.
    Grad H; Grushka M; Yanover L
    J Can Dent Assoc; 1985 Apr; 51(4):296-300. PubMed ID: 3891040
    [No Abstract]   [Full Text] [Related]  

  • 57. Salivary secretion in health and disease.
    Pedersen AML; Sørensen CE; Proctor GB; Carpenter GH; Ekström J
    J Oral Rehabil; 2018 Sep; 45(9):730-746. PubMed ID: 29878444
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A comparison of artificial saliva and pilocarpine in the management of xerostomia in patients with advanced cancer.
    Davies AN; Daniels C; Pugh R; Sharma K
    Palliat Med; 1998 Mar; 12(2):105-11. PubMed ID: 9616446
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Xerostomia in the elderly: prevalence, diagnosis, complications and treatment.
    Ben-Aryeh H; Miron D; Berdicevsky I; Szargel R; Gutman D
    Gerodontology; 1985; 4(2):77-82. PubMed ID: 3867609
    [No Abstract]   [Full Text] [Related]  

  • 60. The Efficacy of a Dietary Supplement with Carnosine and Hibiscus Sabdariffa L. (AqualiefTM) in Patients with Xerostomia: a Randomized, Placebo-Controlled, Double-Blind Trial.
    Levrini L; Azzi L; Bossi S
    Clin Ter; 2020; 171(4):e295-e301. PubMed ID: 32614361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.